BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17018029)

  • 1. Anion exchanger 2 mediates the action of arsenic trioxide.
    Pan XY; Chen GQ; Cai L; Buscemi S; Fu GH
    Br J Haematol; 2006 Sep; 134(5):491-9. PubMed ID: 17018029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.
    Zheng PZ; Wang KK; Zhang QY; Huang QH; Du YZ; Zhang QH; Xiao DK; Shen SH; Imbeaud S; Eveno E; Zhao CJ; Chen YL; Fan HY; Waxman S; Auffray C; Jin G; Chen SJ; Chen Z; Zhang J
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7653-8. PubMed ID: 15894607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
    Chen GQ; Zhou L; Styblo M; Walton F; Jing Y; Weinberg R; Chen Z; Waxman S
    Cancer Res; 2003 Apr; 63(8):1853-9. PubMed ID: 12702573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
    Li L; Wang J; Ye RD; Shi G; Jin H; Tang X; Yi J
    J Cell Physiol; 2008 Nov; 217(2):486-93. PubMed ID: 18636556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid.
    Jiang G; Albihn A; Tang T; Tian Z; Henriksson M
    Leuk Res; 2008 Feb; 32(2):297-307. PubMed ID: 17706770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR; Jena RK
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines.
    Davison K; Côté S; Mader S; Miller WH
    Leukemia; 2003 May; 17(5):931-40. PubMed ID: 12750708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profile changes in NB4 cells induced by arsenic trioxide.
    Wang HY; Liu SX; Zhang M
    Acta Pharmacol Sin; 2003 Jul; 24(7):646-50. PubMed ID: 12852829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.
    Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS
    Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
    Amadori S; Fenaux P; Ludwig H; O'dwyer M; Sanz M
    Curr Med Res Opin; 2005 Mar; 21(3):403-11. PubMed ID: 15811209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arsenic trioxide on the cerulein-induced AR42J cells and its gene regulation.
    Xue D; Zhang W; Liang T; Zhao S; Sun B; Sun D
    Pancreas; 2009 Oct; 38(7):e183-9. PubMed ID: 19730151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway.
    Zhou J; Ye J; Zhao X; Li A; Zhou J
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):33-40. PubMed ID: 18387645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide in the management of acute promyelocytic leukaemia.
    Mathews V; Chandy M; Srivastava A
    Natl Med J India; 2001; 14(4):215-22. PubMed ID: 11547528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent reducing effects of vitamin D3 on the frequency of apoptosis induced by arsenic trioxide in NB4 cell line.
    Mozdarani H; Asghari F
    Arch Iran Med; 2010 Jan; 13(1):26-33. PubMed ID: 20039766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.
    Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U
    Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
    Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide.
    Shackelford D; Kenific C; Blusztajn A; Waxman S; Ren R
    Cancer Res; 2006 Dec; 66(23):11360-9. PubMed ID: 17145882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
    Cheng B; Yang X; Han Z; An L; Liu S
    Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.